11/14/2024
5:07 PM | EcoR1 Capital, LLC (Filed by)
Hookipa Pharma (Subject)
| Form SC 13G/A | |
08/30/2024
7:04 AM | Hookipa Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
4:15 PM | Hookipa Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024
4:27 PM | Hookipa Pharma (Filer)
| Form 424B5 | |
08/02/2024
5:38 PM | Hookipa Pharma (Subject)
Invus Global Management, LLC (Filed by)
| Form SC 13G/A | |
07/24/2024
3:17 PM | Hookipa Pharma (Issuer)
Peters Malte (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2024
3:18 PM | Coelho Mary Theresa (Reporting)
Hookipa Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
07/24/2024
3:15 PM | Cassidy Sean A (Reporting)
Hookipa Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/24/2024
3:16 PM | Cassidy Sean A (Reporting)
Hookipa Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2024
6:00 AM | Hookipa Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/08/2024
5:51 PM | Artal International S.C.A. (Filed by)
Hookipa Pharma (Subject)
| Form SC 13G | |
06/14/2024
5:52 PM | BAKER BROS. ADVISORS LP (Filed by)
Hookipa Pharma (Subject)
| Form SC 13D | |
06/04/2024
3:15 PM | Hookipa Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/31/2024
4:25 PM | EcoR1 Capital, LLC (Filed by)
Hookipa Pharma (Subject)
| Form SC 13G | |
05/23/2024
4:05 PM | Hookipa Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
6:03 AM | Hookipa Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
6:04 AM | Hookipa Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/25/2024
6:10 AM | Hookipa Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/17/2024
3:15 PM | Hookipa Pharma (Issuer)
Necina Roman (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
3:15 PM | Hookipa Pharma (Issuer)
Kandera Reinhard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
3:15 PM | Hookipa Pharma (Issuer)
Winderlich Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
3:15 PM | Aldag Jorn (Reporting)
Hookipa Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
3:15 PM | Hookipa Pharma (Issuer)
Orlinger Klaus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/11/2024
3:19 PM | Hookipa Pharma (Issuer)
Winderlich Mark (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/22/2024
6:33 AM | Hookipa Pharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/22/2024
6:08 AM | Hookipa Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
4:47 PM | Hookipa Pharma (Subject)
| Form SC 13G/A | |
02/14/2024
4:47 PM | EcoR1 Capital, LLC (Filed by)
EcoR1 Capital, LLC (Filed by)
Hookipa Pharma (Subject)
| Form SC 13G/A | |
01/31/2024
3:30 PM | Hookipa Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/29/2024
7:12 AM | Hookipa Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
11:15 PM | Hookipa Pharma (Filer)
| Form EFFECT | |
12/22/2023
3:07 PM | GILEAD SCIENCES, INC. (Reporting)
Hookipa Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/22/2023
6:33 AM | Hookipa Pharma (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
12/21/2023
6:06 AM | Hookipa Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
